See analyst estimates and all valuation multiples for Small Molecules
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $36.8B | 2.2x | 7.7x | |
| $5.7B | 31.8x | 91.2x | |
| $4.3B | 9.1x | 26.9x | |
| $3.6B | 37.7x | -37.8x | |
| $2.7B | 3.3x | 16.4x | |
| $2.6B | 96.5x | -71.9x | |
| $2.6B | 12.0x | -10.1x | |
| $2.2B | 0.9x | 6.3x | |
| $2.1B | 9.3x | 22.2x | |
| $1.4B | 6.0x | 26.6x | |
| $1.3B | 5.4x | 16.1x | |
| $1.2B | 6.0x | 28.6x | |
| $1.2B | n/a | n/a | |
| $987M | n/a | n/a | |
| $825M | 3.7x | 75.0x | |
| $636M | 5.5x | n/a | |
| $596M | 7.1x | 19.8x | |
| $580M | 2.3x | 6.6x | |
| $491M | 38.7x | n/a | |
| $406M | 4.1x | n/a | |
| $340M | 5.5x | -4.9x | |
| $311M | n/a | -23.1x | |
| $296M | 1114.8x | n/a | |
| $285M | 82.7x | n/a | |
| $239M | 2.3x | -60.5x | |
| $189M | 8.3x | n/a | |
| $167M | n/a | n/a | |
| $147M | 5.7x | -6.1x | |
| $143M | 1.1x | -6.1x | |
| $131M | n/a | -5.3x | |
| $88.6M | 3.1x | -0.8x | |
| $84.7M | 8.6x | n/a | |
| $80.7M | 8.5x | n/a | |
| $67.2M | n/a | -0.6x | |
| $58.1M | 1.2x | n/a | |
| $3.6M | 1.8x | n/a | |
| -$34.3M | n/a | 0.3x | |
| -$100M | n/a | n/a | |
| -$163M | -8.5x | 0.9x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Small Molecules